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Objective: To evaluate the activity of erythromycin, roxithromycin, ciprofloxacin, doxycycline, sulfamethoxazole 
trimethoprim and rifampin against 32 strains of Legionella spp. under different testing conditions. 
Methods: Minimum inhibitory concentrations (MICs) were determined by the E-test (Ab Biodijk, Solna, Sweden) and 
agar dilution reference technique (National Committee for Clinical Laboratory Standards (NCCLS), 1990) on two different 
media, buffered charcoal yeast extract agar (BCYE-a) and buffered yeast extract agar (BYE-u), under 48- and 72-h 
incubation, without COS. 
Results: All the antimicrobial agents were inhibited by BCYE-a agar. The MI& values on BYE-cc were lower than those 
on BCYE-a but the variation factor was not the same: ciprofloxacin and rifampin, followed by erythromycin, suffered the 
greatest inhibition by the charcoal in the culture medium. Except for ciprofloxacin and rifampin, the 72-h MIC90 readings 
were always higher than the 48-h results whenever the agar dilution method was used. The E-te,;t results showed slight 
variations with some, but not all, antibiotics. The most active agents against the 32 Legionella strains tested were 
rifampin and ciprofloxacin. 
Conclusions: BCYE-a is not suitable for susceptibility testing of Legionella spp. The E-test method on BYE-a agar with 
48-h incubation is recommended. 
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INTRODUCTION 
Since 1976, Legionella spp. have been recognized as a 
significant cause of lower respiratory infections [ 1-31, 
Clinical experience and retrospective analysis support 
the choice of erythromycin for the treatment of 
confirmed cases. Rifampin should be used in addition 
to erythromycin in patients who are severely ill or 
immunocompromised. The combined therapy is gen- 
erally thought to produce a more favorable outcome in 
serious legionellosis. There have also been favorable 
reports of the use of fluoroquinolones. 
The in vitro testing of antimicrobial agents 
correlates poorly with clinical efficacy. One  possible 
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explanation is that the intracellular location of the 
microorganisms may protect them from otherwise 
effective antimicrobial therapy. Studies based on the 
survival of infected animals and c m  the reduction of the 
number of bacteria in phagocytic cells suggest that only 
drugs such as macrolides, quinolones and rifampin, 
which are able to accumulate in phagocytes, will be 
efficacious in the treatment of legionellosis [4]. 
The clinical importance of greater inhibitory 
activity or of bactericidal activity is uncertain, but it is 
possible that such activity may allow a shorter course of 
therapy without danger of relapse. 
There is no standard method at present for the 
determination of the niininium inhibitory concentra- 
tions (MICs) of antibiotics agains c Legionellu spp. Several 
studies have indicated that the charcoal or other 
components of buffered charcoal yeast extract (BCYE- 
a) medium inhibit the activity of the antimicrobials 
evaluated [5-81. In 1994, Rhoinberg and coworkers 
reported that the E-test MIC 01-1 BCYE-a provided a 
simple and accurate method unaffected by medium 
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components for susceptibility testing of Legionella spp. 
[9]. The aim of this study was determination of the 
susceptibility of 32 strains of Legionella spp. (30 of them 
isolated in Portugal) to six antimicrobial agents, 
comparing the results of MICs determined by the E- 
test and by the agar dilution techniques, assayed on two 
different media (with and without charcoal) with 48-h 
and 72-h incubation, without C02. As far as we know, 
there are no reports of in vitro resistance to these 
antimicrobial agents. 
MATERIALS AND METHODS 
Cultures 
Thirty two Legionella strains were tested (30 of them 
isolated in our laboratory), including: 16 clinical 
isolates, L. pneumophila serogroup (sg) 1 (1 5 strains) and 
sg 14 (one strain); and 14 environmental isolates; 
L. pneumophila sg 1 (six strains) and sg 10 (one strain) 
and seven other Legionella spp. Two collection strains 
were also tested: L. pneumophila sg 1 (Philadelphia 1) 
and L. micdadei (Tatlock) ATCC 33218. A reference 
strain, Staphylococcus aureus ATCC 25923, was selected 
as a control. 
Antibiotics 
Six antimicrobial agents were tested by both tech- 
niques. For the agar dilution method, standard powders 
were obtained from the following sources: erythro- 
mycin (Abbott Laborat6rios, Lda, Lisboa), roxi- 
thromycin (Roussel Portugal-Indhstria Farmachtica, 
Lda., Lisboa), ciprofloxacin (Bayer Portugal, S.A.) 
doxycycline (Laboratbrios Pfizer), sulfamethoxazole/ 
trimethoprim (Roche Farmackutica Quimica, Lda.), 
and rifampin (Marion Merrell Dow, Sociedade 
Quimica, S.A.). Doxycycline and ciprofloxacin were 
dissolved in sterile distilled water and sulfamethoxazole 
trimethoprim in 100% methanol. Erythromycin, 
roxithromycin and rifampin were dissolved in 70% 
aqueous ethanol and then diluted in sterile distilled 
water in order to yield the final concentration required. 
For the E-test, antibiotic strips of the same anti- 
microbials were also kindly supplied (Dario Correia, 
Lda., Lisboa and Izasa Portugal). 
Media 
The media used for susceptibility testing were: 
Mueller-Hinton agar (Oxoid), buffered charcoal yeast 
extract agar (BCYE-a, Oxoid) [lo], and buffered 
yeast extract agar (BYE-a) containing agar (17.00 g/L), 
yeast extract (10.00 g/L), ACES (2-acetamide-2- 
aminomethanesulfonic acid) buffer (1 0.0 g/l00 mL), 
a-ketoglutarate (1 .OO g/100 mL), L-cysteine hydro- 
chloride (0.40 g/100 mL) and ferric pyrophosphate 
(0.25 g/100 mL) [ l l ] .  
Methodology 
For inoculum preparation, 48-h cultures of legionellae 
were prepared on BCYE-a. A control strain inoculum 
of S. aureus was prepared from a 24-h culture on 
Mueller-Hinton agar. From the cultures on agar media, 
suspensions on 10 mL of Mueller-Hinton broth 
(Oxoid) were prepared to contain approximately lo7 
colony-forming units (CFU) per mL, by comparing 
them with a 0.5 McFarland standard. 
The agar dilution method was performed 
according to the procedures described by the NCCLS 
[12]. The plates were inoculated with 10 pL of the 
suspension, to give a final concentration of lo5 CFU 
per spot. The antimicrobials were diluted from stock 
solutions in their appropriate solvent and added to the 
cooled molten media (BCYE-a, BYE-a and Mueller- 
Hinton agar). Concentrations ranged from 32 pg/mL 
to 0.125 pg/mL. Antibiotic-free control media with 
the appropriate solvent were inoculated in parallel with 
the suspensions, and sterility control plates were also 
made. 
The MIC was defined as the lowest concentration 
of antimicrobial at which complete inhibition of visible 
growth or growth of less than five colonies per spot was 
observed according to the criterion of Edelstein and 
Meyer [13]. MIC5o and MIC9" were defined as the 
lowest antibiotic concentrations showing inhibition of 
50% and 90%, respectively, of the strains studied. 
The inoculum for E-tests (AB Biodisk, Solva, 
Sweden) was made with the same suspension, swabbed 
on the surface of a 90-mm plate with a depth of 4 mm. 
One strip per plate was applied to the surface. 
Antimicrobial-gradient plastic strips with an MIC 
scale in a continuous-range concentration of each 
drug were used: erythromycin (0.01 6-256 pg/mL), 
roxithromycin (0.016-256 pg/mL), ciprofloxacin 
(0.002-32 pg/mL), doxycycline (0.016-256 pg/mL), 
sulfamethoxazole-trimethoprim (0.002-32 pg/mL) 
and rifampin (0.002-32 pg/mL); these are the lowest- 
gradient plastic strips in existence. MICs were read 
directly from a scale on the strip at the point where the 
ellipse of growth inhibition intercepted the strip [14]. 
The MICs were read after 24 h (S. aureus only), 48 h 
and 72 h of incubation (without CO2). 
RESULTS AND DISCUSSION 
The results obtained with the control strain S. aureus on 
Mueller-Hinton agar, under 24 h incubation, complied 
with the reference MIC values. All the antimicrobial 
agents were inhibited by BCYE-a. A slight inhibition 
of erythromycin and a strong inhibition of both roxi- 
thromycin and ciprofloxacin occurred, as determined by 
the MICs obtained with the control strain S. aureus on 
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BCYE-a (with charcoal), and Mueller-Hinton agar and 
BYE-a (without charcoal). 
The results of both methods are shown in Table 1 
(MICso and MICgo) and Table 2 (MIC range). The 
most active agents were rifampin and ciprofloxacin. In 
general, higher MIC values were obtained with the 
agar dilution method than with the E-test. 
In the agar dilution method, under all conditions, 
the 72 h MICs were higher than those read at 48 h, 
except in the cases of ciprofhxacin (BYE-a and of 
Table 1 MICso and MICgo ( p g l d ) ,  by agar dilution and by Etest, of six antibiotics for 32 strains of Legionella spp. on 
different mema and with different incubation times 
Agar dilution E-teyt 
BCYE-a BYE-a BCY E-a 13YE-a 
M H  M H  ~~ 
2 4 h  4811 7 2 h  4 8 h  7 2 h  2 4 h  4 8 h  7 2 h  4 8 h  7211 
Ciprofloxacin 
MIC Staph. 
MICso Leg. 
MICcio Leg. 
Erythromycin 
MIC Staph. 
MICjo Leg. 
MICsn Leg. 
Rifampin 
MIC Staph. 
MICso Leg. 
MICw Leg. 
Koxithromyciri 
MIC Staph. 
MICSU Leg. 
MIC9o Leg. 
1 
0.5 
4 . 1 2 5  
1 
Sulfaniethoxazole/Trnnethoprim 
MIC Staph. 0.5 
MIC=,o Leg. 
MICgo Leg. 
Doxycychne 
MIC Staph. 
MICw Leg. 
MlCc~o Leg. 
0.25 
8 
2 
4 
2 
1 
8 
0.5 
10.125 
4 . 1 2 5  
4 
1 
4 
4 
4 
8 
1 
4 
8 
16 2 
2 10.125 
4 <0.125 
2 0.5 
2 0.25 
8 1 
0.5 4 . 1 2 5  
4 . 1 2 5  <0.125 
<0.125 4 . 1 2 5  
4 1 
2 <0.125 
8 0.250 
8 2 
8 2 
8 8 
2 0.25 
8 1 
32 4 
2 0.75 
<0.125 
4 . 1 2 5  
1 0.5 
0.5 
4 
4 . 1 2 5  0.008 
4 . 1 2 5  
4 . 1 2 5  
1 0.75 
4 . 1 2 5  
0.500 
4 0.38 
4 
16 
0.5 0.25 
1 
16 
12 
0.5 
0.75 
3 
0.38 
2 
1 
0.023 
0.094 
4 
0.25 
1.5 
4 
0.25 
0.75 
2 
2 
3 
12 2 2 
0.5 0.006 0.006 
0.75 0.012 0.012 
3 0.5 0.75 
0.38 0.094 0.094 
2 0.25 0.25 
3 0.023 0.023 
0.023 <0.002 <0.002 
o ,094 < o . no2 < o. no2 
4 2 2 
0.25 0.010 0.016 
1.5 0.064 0.38 
4 2 2 
0.38 0.19 0.25 
0.75 0.5 0.75 
2 0.5 0.5 
3 0.5 0.75 
4 0.75 1 
MH, Mueller-Hmton agar; BCYE-a, buffered charcoal yeast agar; BYE-a, buffered yeast extract agar; MlC St:tph., MIC of S. ~IUICLIS 
control strain; MIC Leg., MIC of Legiunella spp. strains. 
Table 2 MIC (pg/mL) ranges of six antimicrobials for 32 strains of Legionella spp. by the E-test and the agar dilition techniques (with 48-h 
incubation) 
MIC ranges 
Agar dilution method E-test 
Antimicrobials BCYE BYE BCYE BYE 
Erythromycin 0.5-8 0.1 25-2 0.125-8 0.016-1 
Roxithromycin 0.5-4 < 0.125-0.5 0 . 1 2 5 4  < 0.01 6-0.5 
Rifampin <0.125 <0.125 0.16-0.5 <0.002 
Iloxycychne 2-8 0.125-4 1-6 0.016-1 
Ciprofloxacin 0 . 5 4  < 0.125 0.250-1 0.002-0.032 
Sulfamethoxazole/Trimethoprim 2-16 0.125-16 0.125-1 .5 0.002- 1 
368  C l in ica l  M i c r o b i o l o g y  and  In fec t i on ,  Vo lume 3 Number  3, June  1997 
rifampin, where there was no growth at the lowest 
concentration tested. In the E-test, growth after 48 h 
allowed easy reading of the MIC, and further 
incubation resulted in only slight variation. The 
extreme susceptibility of Legionella spp. to rifampin has 
been observed previously [9]; we used the E-test strips 
with the lowest MIC range available. 
The MI& and MIC9" values on BYE-a were 
lower than those on BCYE-a for all the antimicrobials 
concerned. However, the charcoal in the culture 
medium affected doxycycline and sulfamethoxazole/ 
trimethoprim less than erythromycin, while cipro- 
floxacin and rifampin suffered the greatest inhibition. 
In opposition to the opinion of Rhomberg et al. 
[9], we believe that BCYE-a is not a suitable niediuni 
for susceptibility testing of Legionella spp., because of 
the inhibitory action of the charcoal. This inhibitory 
action was shown with the control strain of S. aweus 
and with the Legionella strains studied, and with all six 
antimicrobial agents used. O n  BYE-a, the S. aureus 
control demonstrated the reference values. The E-test 
method on BYE-a with 48 h incubation may be a 
good option to choose for the in vitro testing of the 
susceptibility of Legionellu spp. to antimicrobials. 
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